FNY Managed Accounts’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
KKRC
FNY Managed Accounts's AMED Position: Q1 2018 in Review
FNY Managed Accounts sold out of Amedisys (AMED) in Q1 2018, closing a stake of 6,500 shares — an estimated $342K sold.
FNY Managed Accounts first reported a position in AMED in Q2 2015 and held it in 3 quarters. The position peaked at $900K in Q3 2017. 194 funds tracked by Wall St. Rank hold AMED as of Q1 2018.
- FNY Managed Accounts reported no remaining Amedisys position as of Q1 2018 after selling out during the quarter.
- FNY Managed Accounts sold 6,500 Amedisys shares in Q1 2018, an estimated $342K.
- FNY Managed Accounts first reported a position in Amedisys in Q2 2015 and held it in 3 quarters.
- FNY Managed Accounts's Amedisys position peaked at $900K in Q3 2017.
- 194 funds tracked by Wall St. Rank held Amedisys as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.